Wanbury Limited (BOM:524212)

Market Cap	9.07B
Revenue (ttm)	6.00B
Net Income (ttm)	305.30M
Shares Out	32.76M
EPS (ttm)	8.98
PE Ratio	30.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,004
Average Volume	8,439
Open	300.05
Previous Close	300.30
Day's Range	290.60 - 304.70
52-Week Range	151.10 - 330.00
Beta	0.34
RSI	43.66
Earnings Date	Jun 20, 2025

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive t...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 1,491
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524212

Financial Performance

In 2024, Wanbury's revenue was 6.00 billion, an increase of 4.15% compared to the previous year's 5.76 billion. Earnings were 305.30 million, a decrease of -45.44%.